Mates Sharon's Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Aug 28, 2024
- Accession no.
- 0000950170-24-101506
- Filed
- Aug 28, 2024
- Trade date
- Aug 26-28, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $7.05M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mates SharonCIK 0001585699 | Director, Officer (Chairman and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Common Stock | MOption exerciseAcquired | +22,713 | $17.57 | +$399,067.41 | 1,093,042 | Direct | |
| Aug 26, 2024 | Common Stock | SSaleDisposed | −22,713 | $74.59 | −$1,694,162.67 | 1,070,329 | Direct | |
| Aug 27, 2024 | Common Stock | MOption exerciseAcquired | +40,513 | $17.57 | +$711,813.41 | 1,110,842 | Direct | |
| Aug 27, 2024 | Common Stock | SSaleDisposed | −23,657 | $73.33 | −$1,734,767.81 | 1,087,185 | Direct | |
| Aug 27, 2024 | Common Stock | SSaleDisposed | −16,856 | $73.93 | −$1,246,164.08 | 1,070,329 | Direct | |
| Aug 28, 2024 | Common Stock | MOption exerciseAcquired | +32,699 | $17.57 | +$574,521.43 | 1,103,028 | Direct | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −32,459 | $72.74 | −$2,361,067.66 | 1,070,569 | Direct | |
| Aug 28, 2024 | Common Stock | SSaleDisposed | −240 | $73.70 | −$17,688 | 1,070,329 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Common Stock | MOption exerciseDisposed | −22,713 | $0.00 | $0 | 73,212 | Direct | |
| Aug 27, 2024 | Common Stock | MOption exerciseDisposed | −40,513 | $0.00 | $0 | 32,699 | Direct | |
| Aug 28, 2024 | Common Stock | MOption exerciseDisposed | −32,699 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.